Genus plc
United Kingdom · GB0002074580 · reports in GBP · Europe
The answers
From the annual report for the year to Jun 30, 2025. Each line says what it is based on.
- Is it growing?Fair
- Revenue +0.6% in the year to Jun 30, 2025, on the year before.
- Is it a good business?To watch
- It earned 4.1% on its shareholders' equity in the year to Jun 30, 2025.
- Is it safe?Good
- Equity is 53% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Jun 30, 2025, consolidated, in GBP.
revenue
operating margin
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 | |
|---|---|---|---|---|
| Revenue | £593M | £690M | £669M | £673M |
| Operating profit | £49M | £41M | £6M | £42M |
| Net profit to shareholders | £41M | £33M | £8M | £19M |
| Earnings per share | £0.63 | £0.51 | £0.12 | £0.29 |
| Cash from operations | −£67M | −£31M | £30M | £67M |
| Capital spending | £42M | £26M | £15M | £13M |
| Cash | £39M | £36M | £43M | £48M |
| Total assets | £1.0B | £1.0B | £988M | £899M |
| Equity | £572M | £567M | £514M | £476M |
What they do
In the company's own words, from the annual report.
We produce and sell elite animal genetics to farmers. Animals bred from these genetics have traits that farmers value, such as feed conversion efficiency, disease resistance and faster growth. Our genetics therefore enable farmers to raise healthier animals that produce more high-quality protein per unit of input. This increases farmer profitability and food supply resilience, and reduces the environmental impact of animal protein production.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.